The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin

The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin

Aim. The usefulness of photodynamic therapy (PDT) for treating sentinel lymph node (SLN) metastasis was evaluated. Materials and Methods. Verteporfin, a hydrophobic photosensitizer, forms a soluble aggregate with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) (PMB). The conce...

Full description

Bibliographic Details
Main Authors:	Kyosuke Shimada, Sachiko Matsuda, Hiromitsu Jinno, Noriaki Kameyama, Tomohiro Konno, Tsunenori Arai, Kazuhiko Ishihara, Yuko Kitagawa
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/7412865

Similar Items

Photodynamic Therapy with Verteporfin for Choroidal Metastasis Refractory to Radiotherapy
by: Raymond Zhou, et al.
Published: (2019-11-01)

Quantum Interference Effects in Nanotransport
by: Chun-Jen Cheng, et al.
Published: (2007)

Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization
by: Hussain Nazimul, et al.
Published: (2006-01-01)

Verteporfin photodynamic therapy of retinal capillary hemangioblastoma in von Hippel-Lindau disease
by: Bhattacharjee Harsha, et al.
Published: (2010-01-01)

Photoproducts of the Photodynamic Therapy Agent Verteporfin Identified via Laser Interfaced Mass Spectrometry
by: Chris Furlan, et al.
Published: (2020-11-01)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
by: Pierluigi Iacono, et al.
Published: (2020-10-01)

Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
by: Thierry Michy, et al.
Published: (2019-11-01)

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.
by: BC Reeves, et al.
Published: (2012-02-01)

Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
by: Alfredo Pece, et al.
Published: (2010-05-01)

Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy
by: Tock-Han Lim, et al.
Published: (2013-06-01)

Photodynamic therapy with one third-dose verteporfin for treating acute central serous chorioretinopathy
by: Bo Zheng, et al.
Published: (2013-08-01)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
by: Sanguansak T, et al.
Published: (2015-12-01)

Single-Cycle Autocorrelation in Attosecond Coherent Nanotransport
by: M. Ludwig, et al.
Published: (2019-01-01)

A case of presumed choroidal metastasis from carcinoid tumor treated by photodynamic therapy with verteporfin
by: Kawakami S, et al.
Published: (2013-10-01)

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
by: Dhirani NA, et al.
Published: (2017-12-01)

Retrospective study on half-dose verteporfin photodynamic therapy for treatment of chronic central serous chorioretinopathy
by: Xin Sun, et al.
Published: (2015-10-01)

Micro/Nanotransport Phenomena in Renewable Energy and Energy Efficiency
by: G. P. “Bud” Peterson, et al.
Published: (2010-01-01)

Hyperbranched Polyglycerol Derivatives as Prospective Copper Nanotransporter Candidates
by: Mohiuddin Quadir, et al.
Published: (2018-05-01)

Micro/Nanotransport Phenomena in Renewable Energy and Energy Efficiency
by: Chen, Gang, et al.
Published: (2011)

Water-Soluble and Cytocompatible Phospholipid Polymers for Molecular Complexation to Enhance Biomolecule Transportation to Cells in Vitro
by: Kazuhiko Ishihara, et al.
Published: (2020-08-01)

Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
by: Lai Timothy YY, et al.
Published: (2011-05-01)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
by: Tsuchihashi T, et al.
Published: (2013-03-01)

Efficacy of half-dose verteporfin photodynamic therapy for central serous chorioretinophathy in patients aged above 45
by: Yi-Jun Wu, et al.
Published: (2017-11-01)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
by: Maribel Fernández, et al.
Published: (2012-01-01)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
by: Alkin Z, et al.
Published: (2014-04-01)

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
by: Alexander S. Sobolev, et al.
Published: (2018-08-01)

Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery
by: Sylvie Skalickova, et al.
Published: (2017-12-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
by: Rosalia Giustolisi, et al.
Published: (2014-09-01)

Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin
by: Obochi, Modestus Onuora Kay
Published: (2009)

Prevention of skin allograft rejection by photodynamic therapy (PDT) using benzoporphyrin derivative monoacid ring A (BPD) verteporfin
by: Obochi, Modestus Onuora Kay
Published: (2009)

Non-Orthogonality and Electron Correlations in Nanotransport : Spin- and Time-Dependent Currents
by: Fransson, Jonas
Published: (2002)

Optical 3D-Nanometry to Study the Function of Biomolecular Motors in Nanotransport
by: Nitzsche, Bert
Published: (2009)

Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters
by: Slastnikova TA, et al.
Published: (2017-01-01)

Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas
by: Jeffrey D. Rytlewski, et al.
Published: (2021-02-01)

Improvement of Low Luminance Visual Acuity in Patients with Chronic Central Serous Chorioretinopathy after Half-Dose Verteporfin Photodynamic Therapy
by: Kyoko Fujita, et al.
Published: (2020-12-01)

Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
by: Prashant Jain, et al.
Published: (2018-01-01)

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
by: Shun Kumashiro, et al.
Published: (2021-05-01)

β‑Lactoglobulin as a Nanotransporter for Glabridin: Exploring the Binding Properties and Bioactivity Influences
by: Yongqin Wei, et al.
Published: (2018-09-01)

Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery
by: Slastnikova TA, et al.
Published: (2012-02-01)

Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
by: Atul Kumar, et al.
Published: (2018-01-01)